Previous studies have reported that 5 to 27% of patients with DTCs develop locoregional recurrences.25Such recurrences have been reported to be located in cervical lymph nodes in 60 to 75% of cases and thyroid bed in approximately 20% of cases, worsening the prognosis and leading to a risk of cancer-related death.25A slightly higher incidence is noted among our group due to the already present posttreatment elevated Tg level as a risk factor. The gene discussed is TG; the disease is cancer.